Literature DB >> 1092601

The distribution of mucosal antibodies in the bowel of patients with Crohn's disease.

F H Green, H Fox.   

Abstract

Specimens of intestine from 24 patients with histologically proven Crohn's disease have been studies by an immunofluorescent technique for the distribution of immunoglobulins A, G, M, E, and D. A marked reduction of IgA in lymphoid and epithelial cells was noted in those areas of the bowel which, although histologically affected, were not ulcerated; in the histologically unaffected areas of the bowel the distribution of IgA was similar to that found in control sections of normal bowel. There was an increase in IG7 in the affected areas but the numbers of lymphoid cells staining for IgD did not differ from those found in normal controls; in 12 cases of Crohn's disease, however, IgG appeared to be present in bound form on the surface of, and in, the epithelial cells. It is postulated that the local deficiency in IgA in the affected areas may be secondary to a local cell-mediated immune reaction, to a focal metaplasia of the surface epithelium, or to patchy bindings of anticolon antibodies to the surface epithelium. The effect of this local deficiency of IgA will be to allow for an increased focal entry of antigenic material into the bowel wall, and it is suggested that many of the pathological features of Crohn's disease are explicable on the basis of deep penetration of a variety of antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092601      PMCID: PMC1410987          DOI: 10.1136/gut.16.2.125

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  HISTOLOGY OF CROHN'S SYNDROME.

Authors:  W J WILLIAMS
Journal:  Gut       Date:  1964-12       Impact factor: 23.059

2.  CROHN'S DISEASE OF THE LARGE INTESTINE.

Authors:  H E LOCKHART-MUMMERY; B C MORSON
Journal:  Gut       Date:  1964-12       Impact factor: 23.059

3.  Lack of gamma A-immunoglobulin in serum of patients with steatorrhoea.

Authors:  P A Crabbé; J F Heremans
Journal:  Gut       Date:  1966-04       Impact factor: 23.059

4.  Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease.

Authors:  E R Richens; M J Williams; K R Gough; R J Ancill
Journal:  Gut       Date:  1974-01       Impact factor: 23.059

Review 5.  Structure and function of mucosal antibodies.

Authors:  T B Tomasi
Journal:  Annu Rev Med       Date:  1970       Impact factor: 13.739

6.  Immunoglobulin-containing cells in normal jejunal mucosa and in ulcerative colitis and regional enteritis.

Authors:  J Söltoft
Journal:  Scand J Gastroenterol       Date:  1969       Impact factor: 2.423

7.  Immunoglobulins in non-specific ulcerative disease of the colon. A preliminary report.

Authors:  P F Schofield; S D Deodhar; R B Turnbull
Journal:  J R Coll Surg Edinb       Date:  1969-05

8.  The immunoglobulin concentrations in serum and bowel secretion in patients with Crohn's disease.

Authors:  L Bergman; S G Johansson; U Krause
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

9.  Intestinal uptake of macromolecules: effect of oral immunization.

Authors:  W A Walker; K J Isselbacher; K J Bloch
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

10.  The distribution of large dividing lymph node cells in syngeneic recipient rats after intravenous injection.

Authors:  C Griscelli; P Vassalli; R T McCluskey
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

View more
  20 in total

1.  Value of counting colonic mucosal Ig-containing cells in the differential diagnosis of chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; S G Meuwissen; N W Schipper; B C Morson; J Lindeman; C J Meijer
Journal:  J Clin Pathol       Date:  1992-03       Impact factor: 3.411

2.  Mast cells and immunoglobulin E in inflammatory bowel disease.

Authors:  G Lloyd; F H Green; H Fox; V Mani; L A Turnberg
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

3.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.

Authors:  C A Seldenrijk; B C Morson; S G Meuwissen; N W Schipper; J Lindeman; C J Meijer
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

4.  Immunological study of histologically non-involved jejunum during Crohn's disease: evidence for reduced in vivo secretion of secretory IgA.

Authors:  P Marteau; J F Colombel; J Nemeth; J P Vaerman; J C Dive; J C Rambaud
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

5.  Distribution of immunoglobulin producing cells is different in normal human appendix and colon mucosa.

Authors:  K Bjerke; P Brandtzaeg; T O Rognum
Journal:  Gut       Date:  1986-06       Impact factor: 23.059

6.  Immunohistochemical changes in morphologically involved and uninvolved colonic mucosa of patients with idiopathic proctitis.

Authors:  K M Das; W F Erber; A Rubinstein
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

7.  Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease.

Authors:  E Peen; S Almer; G Bodemar; B O Rydén; C Sjölin; K Tejle; T Skogh
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

8.  Immunoglobulin containing cells in inflammatory bowel disease of the colon: a morphometric and immunohistochemical study.

Authors:  P C Rosekrans; C J Meijer; A M van der Wal; C J Cornelisse; J Lindeman
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

9.  Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations.

Authors:  S G Meuwissen; T M Feltkamp-Vroom; A B De La Rivière; A E Von Dem Borne; G N Tytgat
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

10.  In vitro immunoglobulin secretion by normal human gastrointestinal mucosal tissues, and alterations in patients with inflammatory bowel disease.

Authors:  V A Danis; A D Harries; R V Heatley
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.